In the BioHarmony Drug Report Database
Urokinase
Kinlytic (urokinase) is an enzyme pharmaceutical. Urokinase was first approved as Kinlytic on 1978-01-16. It is used to treat coronary thrombosis, myocardial infarction, pulmonary embolism, vascular graft occlusion, and venous thrombosis in the USA.
Trade Name
|
Kinlytic |
|---|---|
Common Name
|
urokinase |
ChEMBL ID
|
CHEMBL1201420 |
Indication
|
coronary thrombosis, myocardial infarction, pulmonary embolism, vascular graft occlusion, venous thrombosis |
Drug Class
|
Enzymes |
Image (chem structure or protein)
